Stay updated on Ruxolitinib in COVID Cytokine Storm Clinical Trial
Sign up to get notified when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.

Latest updates to the Ruxolitinib in COVID Cytokine Storm Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page’s revision/version label was updated from **v3.5.2** to **v3.5.3**, reflecting a site software update rather than a change to the study information.SummaryDifference0.0%

- Check22 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0. This appears to be a minor version label update with no impact on trial details or visible content.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check58 days agoChange DetectedThe Revision label on the page was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check87 days agoChange DetectedRevision: v3.4.2 is now displayed on the page. The previous government funding lapse notice has been removed, and core study content remains unchanged.SummaryDifference0.3%

- Check94 days agoChange DetectedA site-wide Notice about a lapse in government funding and updated operating status was added, and the page revision indicator changed from v3.4.0 to v3.4.1.SummaryDifference0.3%

Stay in the know with updates to Ruxolitinib in COVID Cytokine Storm Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.